Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lubna Therachiyil

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Tissue Barriers|August 13, 2025
Claudins in ovarian cancer: emerging biomarkers and therapeutic targetsLubna Therachiyil, Ajaz A Bhat, Shahab Uddin
Seminars in Cancer Biology|October 17, 2022
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathwaysLubna Therachiyil, Ola J Hussein, Shahab Uddin, et al.
International Review of Cell and Molecular Biology|May 26, 2026
Advancements in computational tools in proteomics: Revolutionizing data analysisLubna Therachiyil, Anjana Anand, Aamir Ahmad, et al.
Expert Opinion on Therapeutic Targets|November 12, 2025
GADD45: a crucial component of the DNA damage response and a potential cancer therapeutic targetKirti S Prabhu, Lubna Therachiyil, Tariq Masoodi, et al.
Expert Review of Proteomics|January 16, 2025
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancerQueenie Fernandes, Lubna Therachiyil, Shahd M Younis, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2025
SKP2 E3 ligase in urological malignancies: a critical regulator of the cell cycle and therapeutic targetMohannad Natheef AbuHaweeleh, Lubna Therachiyil, Kirti S Prabhu, et al.
F1000Research|December 1, 2022
Role of RAS signaling in ovarian cancerLubna Therachiyil, Anjana Anand, Abdullah Azmi, et al.
International Journal of Molecular Sciences|June 24, 2022
Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition PathwaysLubna Therachiyil, Roopesh Krishnankutty, Fareed Ahmad, et al.
Journal of Proteomics|February 5, 2024
Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistanceLubna Therachiyil, Paleerath Peerapen, Shahd M Younis, et al.
Advances in Protein Chemistry and Structural Biology|November 27, 2025
Protein misfolding and cancer - proteomics as an approach for biomarker discoveryLubna Therachiyil, Gazala Anamangadan, Manel Sadok, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Tissue Barriers|August 13, 2025
Claudins in ovarian cancer: emerging biomarkers and therapeutic targetsLubna Therachiyil, Ajaz A Bhat, Shahab Uddin
Seminars in Cancer Biology|October 17, 2022
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathwaysLubna Therachiyil, Ola J Hussein, Shahab Uddin, et al.
International Review of Cell and Molecular Biology|May 26, 2026
Advancements in computational tools in proteomics: Revolutionizing data analysisLubna Therachiyil, Anjana Anand, Aamir Ahmad, et al.
Expert Opinion on Therapeutic Targets|November 12, 2025
GADD45: a crucial component of the DNA damage response and a potential cancer therapeutic targetKirti S Prabhu, Lubna Therachiyil, Tariq Masoodi, et al.
Expert Review of Proteomics|January 16, 2025
Oncoproteins E6/E7 of the human papillomavirus types 16 & 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancerQueenie Fernandes, Lubna Therachiyil, Shahd M Younis, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2025
SKP2 E3 ligase in urological malignancies: a critical regulator of the cell cycle and therapeutic targetMohannad Natheef AbuHaweeleh, Lubna Therachiyil, Kirti S Prabhu, et al.
F1000Research|December 1, 2022
Role of RAS signaling in ovarian cancerLubna Therachiyil, Anjana Anand, Abdullah Azmi, et al.
International Journal of Molecular Sciences|June 24, 2022
Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition PathwaysLubna Therachiyil, Roopesh Krishnankutty, Fareed Ahmad, et al.
Journal of Proteomics|February 5, 2024
Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistanceLubna Therachiyil, Paleerath Peerapen, Shahd M Younis, et al.
Advances in Protein Chemistry and Structural Biology|November 27, 2025
Protein misfolding and cancer - proteomics as an approach for biomarker discoveryLubna Therachiyil, Gazala Anamangadan, Manel Sadok, et al.
Pageof 4